Los Angeles, CA - May 21, 2016

(Co-hosted by The Angeles Clinic & Research Institute)

Date: Saturday – May  21, 2016
Time:  8:00am – 1:35pm
Location:
InterContinental Hotel
2151 Avenue of the Stars
Los Angeles, CA 90067

Presenters and Topics

TimeAgenda

8:00am

Breakfast and Registration

8:30am

Welcome
Lawrence Piro, MD - Chief Executive Officer
The Angeles Clinic & Research Institute

8:45am

Future Directions for Targeted Therapy - BRAF, NRAS, and more
Jeffrey S. Weber, MD - Deputy Director, Perlmutter Cancer Center
Co-Director Melanoma Program, NYU Langone Medical Center

9:15am

Current Overview of PD-1 Immunotherapy and Predictive Markers
Ryan J. Sullivan, MD - Cancer Immunology/Melanoma
MGH Cancer Center, Massachusetts General Hospital - Harvard Medical School

9:45am

Adoptive T cell Therapy for Metastatic Melanoma
Mark Faries, MD - Director, Donald L Morton Melanoma Research Program
Professor of Surgery; John Wayne Cancer Institute

10:30am

Break

11:00am

Mixed Media: Art and Science of Combination Therapy for Metastatic Melanoma
Morganna Freeman, DO, FACP - Melanoma/Cutaneous Oncology
Moffitt Cancer Center

11:30am

Ocular and Mucosal Melanoma Therapy
Richard Carvajal, MD - Director, Melanoma Experimental Therapeutics
Columbia University Medical Center

12:00pm

The Role of Surgery in the Era of Therapeutic Success in Melanoma
Richard Essner, MD - Co-Director Melanoma Program
Cedars Sinai Medical Center

The Next Frontier - New Checkpoint Pathways & Novel Therapies
Omid Hamid, MD - Director, Melanoma Program
The Angeles Clinic & Research Institute - Cedars Sinai Medical Center

1:00pm

Question and Answer Session

1:30pm

Closing Remarks
Samantha Guild
AIM at Melanoma

Other Information:

Bagels and coffee will be provided.
If you have any questions, please email sguild@AIMatMelanoma.org.

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.